Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.

Source:http://linkedlifedata.com/resource/pubmed/id/16951222

Clin. Cancer Res. 2006 Sep 1 12 17 5064-73

Download in:

View as

General Info

PMID
16951222